OSCR

TYRO3, AXL, MERTK and Their Ligands in Brain Metastases From Colorectal Cancers.

Overview

Authors: Anaïs Noblanc1,2, Fatima Dkhissi1, Pierre‐Olivier Guichet1,2, Lucie Lebeau3, Serge Milin3, Sheik Emambux1,4, Pauline Roussille5, Camille Evrard1,4, Lucie Karayan‐Tapon1,2, David Tougeron1,6, Omar Benzakour1, Violaine Randrian1,6
  1. PRODICET, UR24144, Université de Poitiers, Poitiers, France
  2. Department of Biological Cancerology, CHU de Poitiers, Poitiers, France
  3. Department of Pathology, CHU de Poitiers, Poitiers, France
  4. Department of Oncology, CHU de Poitiers, Poitiers, France
  5. Department of Radiotherapy, CHU de Poitiers, Poitiers, France
  6. Department of Hepatology and Gastroenterology, CHU de Poitiers, Poitiers, France
Journal: Cancer medicine, volume 15, issue 5, article e71869
Dates: received 18 March 2025; accepted 15 April 2026; published online 27 April 2026; in print May 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1002/cam4.71869 · PMID 42043872 · PMCID PMC13117217 · OpenAlex W7155867286
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: human (organism), mouse (organism), other condition (population)
Methods: Statistics
Keywords: AXL, brain metastasis, colorectal cancer, GAS6
MeSH: Brain Neoplasms*, c-Mer Tyrosine Kinase*, Colorectal Neoplasms*, Proto-Oncogene Proteins*, Receptor Protein-Tyrosine Kinases*, Aged, Animals, Axl Receptor Tyrosine Kinase, Cell Line, Tumor, Female, Growth Arrest-Specific Protein 6, Humans, Intercellular Signaling Peptides and Proteins, Ligands, Male, Mice, Middle Aged, Prognosis, Protein S (* major topic)
Topic: Phagocytosis and Immune Regulation (Immunology, Immunology and Microbiology), according to OpenAlex
Funding: Sport et Collection 2020
Citations: not cited yet (Europe PMC); 50 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data availability statement

The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

Read it in the paper: doi.org/10.1002/cam4.71869.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 12 authors, 4 keywords, 19 MeSH terms, 1 funder, 50 references.

Cite

This paper

Noblanc, A., Dkhissi, F., Guichet, P., Lebeau, L., Milin, S., Emambux, S., Roussille, P., Evrard, C., Karayan‐Tapon, L., Tougeron, D., Benzakour, O., & Randrian, V. (2026). TYRO3, AXL, MERTK and Their Ligands in Brain Metastases From Colorectal Cancers. Cancer medicine, 15(5), e71869. https://doi.org/10.1002/cam4.71869

BibTeX

@article{noblanc2026tyro3,
author = {Noblanc, Anaïs and Dkhissi, Fatima and Guichet, Pierre‐Olivier and Lebeau, Lucie and Milin, Serge and Emambux, Sheik and Roussille, Pauline and Evrard, Camille and Karayan‐Tapon, Lucie and Tougeron, David and Benzakour, Omar and Randrian, Violaine},
title = {{TYRO3, AXL, MERTK and Their Ligands in Brain Metastases From Colorectal Cancers}},
journal = {Cancer medicine},
year = {2026},
month = may,
volume = {15},
number = {5},
pages = {e71869},
publisher = {Wiley},
issn = {2045-7634},
doi = {10.1002/cam4.71869},
url = {https://doi.org/10.1002/cam4.71869},
pmid = {42043872},
pmcid = {PMC13117217}
}

RIS

TY - JOUR
AU - Noblanc, Anaïs
AU - Dkhissi, Fatima
AU - Guichet, Pierre‐Olivier
AU - Lebeau, Lucie
AU - Milin, Serge
AU - Emambux, Sheik
AU - Roussille, Pauline
AU - Evrard, Camille
AU - Karayan‐Tapon, Lucie
AU - Tougeron, David
AU - Benzakour, Omar
AU - Randrian, Violaine
TI - TYRO3, AXL, MERTK and Their Ligands in Brain Metastases From Colorectal Cancers
T2 - Cancer medicine
J2 - Cancer Med
PY - 2026
DA - 2026/05/01
VL - 15
IS - 5
SP - e71869
SN - 2045-7634
PB - Wiley
DO - 10.1002/cam4.71869
UR - https://doi.org/10.1002/cam4.71869
LA - en
ER -

CSL-JSON

{
"id": "10.1002/cam4.71869",
"type": "article-journal",
"title": "TYRO3, AXL, MERTK and Their Ligands in Brain Metastases From Colorectal Cancers",
"container-title": "Cancer medicine",
"author": [
{
"family": "Noblanc",
"given": "Anaïs"
},
{
"family": "Dkhissi",
"given": "Fatima"
},
{
"family": "Guichet",
"given": "Pierre‐Olivier"
},
{
"family": "Lebeau",
"given": "Lucie"
},
{
"family": "Milin",
"given": "Serge"
},
{
"family": "Emambux",
"given": "Sheik"
},
{
"family": "Roussille",
"given": "Pauline"
},
{
"family": "Evrard",
"given": "Camille"
},
{
"family": "Karayan‐Tapon",
"given": "Lucie"
},
{
"family": "Tougeron",
"given": "David"
},
{
"family": "Benzakour",
"given": "Omar"
},
{
"family": "Randrian",
"given": "Violaine"
}
],
"container-title-short": "Cancer Med",
"volume": "15",
"issue": "5",
"page": "e71869",
"DOI": "10.1002/cam4.71869",
"PMID": "42043872",
"PMCID": "PMC13117217",
"ISSN": "2045-7634",
"publisher": "Wiley",
"URL": "https://doi.org/10.1002/cam4.71869",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41467-026-76587-0 [code]
Uncovering the signaling networks of disseminated glioblastoma cells in vivo with INSIGHT.
Journal: Nature communications
In common: other condition, mouse, 1 reference
[2] doi:10.1038/s41467-026-74782-7
Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8<sup>+</sup> T cell responses and promoting tertiary lymphoid structure formation.
Journal: Nature communications
In common: other condition, mouse, 1 reference
[3] doi:10.1136/jitc-2025-014421
Spatial immune atlas of breast cancer brain metastasis reveals CD163<sup>+</sup> macrophage reprogramming associated with immune escape.
Journal: Journal for immunotherapy of cancer
In common: other condition, 1 reference
[4] doi:10.1038/s41467-026-74037-5
Microglial CD31 suppresses Aβ clearance and promotes Alzheimer pathology in 5×FAD mice.
Journal: Nature communications
In common: mouse, 1 reference
[5] doi:10.7554/elife.107085 [code]
Activity-dependent CO<sub>2</sub> production in the axon triggers opening of Connexin32 in the Schwann cell paranode.
Journal: eLife
In common: other condition, mouse, 1 reference
[6] doi:10.1093/immhor/vlag015
ZBP1 mediated restriction of Toxoplasma gondii in both the early acute and chronic brain stages of infection.
Journal: ImmunoHorizons
In common: other condition, mouse, 1 reference
[7] doi:10.1038/s42003-026-09915-1
Single cell and spatial sequencing analysis of cancer associated fibroblasts in the brain metastasis tumor microenvironment.
Journal: Communications biology
In common: other condition, 1 reference
[8] doi:10.1038/s41598-026-55648-w
Aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microglia.
Journal: Scientific reports
In common: other condition, 1 reference
[9] doi:10.1038/s41467-026-76341-6 [code]
Neonatal inflammation disrupts a temporally restricted postnatal Numb-enriched microglial state in mice.
Journal: Nature communications
In common: mouse, 1 reference
[10] doi:10.1002/cns.70979
1 Hz Low-Frequency Repetitive Transcranial Magnetic Stimulation Ameliorates Epilepsy by Suppressing Interferon-γ Signaling-Dependent Microglial Synaptic Phagocytosis in Mice.
Journal: CNS neuroscience & therapeutics
In common: mouse, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.